Provincial Coverage and Availability
Where and how can I get protection from RSV for my newborn?
Talk to your healthcare provider to understand the options available to you and together make an informed shared-decision how to best protect your infant from RSV disease this RSV season.
Refer to the table below for information about which RSV immunization options are available in your province.
Note: This is the first RSV season these products are available for Canadians. Information on availability and access is subject to change.
At the time of publishing this website, the eligibility criteria for RSV infant programs are publicly available for some provinces and territories. Other provinces and territories have not yet updated/made publicly available their eligibility criteria for the 2024-2025 RSV Season. This site will be updated periodically as new information becomes available. Please check with your healthcare provider or local public health unit for the most up to date information.
Summary of Provincial and Territories RSV Prevention Programs in Infants 1
| BC | AB | SK | MB | ON | QC | NB | NS | PEI | NL | NT | YK | NU | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABRYSVO |  |
||||||||||||
| mAB1 |  |
|
|
|
 |
|
 |
|
|
|
1 Based on media reports. Most provinces have not yet published their eligibility criteria for 2024 – 25 RSV season. NL and PEI are planning HR programs with Nirsevimab and NS considering Nirsevimab for high-risk infants.
Source:
RSV shot will be offered widely in Ontario and Quebec, but not in Western provinces – The Globe and Mail
Ontario – Respiratory Syncytial Virus prevention programs
Alberta – RSV Eligibility Criteria 2024-2025
RSV vaccine now available for all Nunavut babies | CTV News
| ABRYSVO Maternal Program | |
| mAB1 | |
| ABRYSVO | |
| ABRYSVO | |
Alberta
Visit MyHealth Alberta for information on accessing RSV immunization products.
You can also talk to your doctor or pharmacist to inquire whether they carry the maternal RSV vaccine.
British Columbia
Visit Immunize BC for up-to-date information, including a clinic locator to direct you to a pharmacy which carries the maternal RSV vaccine.
Manitoba
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
New Brunswick
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Newfoundland & Labrador
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Northwest Territories
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Nova Scotia
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Nunavut
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Ontario
Ontario is publicly funding RSV immunizations for all infants and high-risk children up to 24 months of age for the 2024-2025 season.
Ontario will also fund the maternal RSV vaccine for pregnant residents between 32 and 36 weeks gestational age who are expected to deliver near the start or during the 2024-2025 RSV season.
Visit the Ontario RSV prevention program website to learn more or contact your local public health unit.
Prince Edward Island
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Quebec
Quebec is publicly funding the RSV infant immunization for babies born within the 2024-2025 season. Visit the Quebec RSV Immunization Page for information about the publicly funded program.
Pregnant people interested in the maternal RSV vaccine should talk to their doctor or pharmacist.
Saskatchewan
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Yukon
Contact your local public health unit or talk to your doctor to inquire about RSV immunization options available for you.
Newfoundland & Labrador
Saskatchewan
Information about infant RSV protective options in Canada for the 2024-2025 RSV Season.
While moving towards a universal program to protect all infants from RSV disease is recommended, not all provinces are implementing a universal program this RSV season. Depending on the province, this could be due to timing, cost effectiveness, logistics for implementation, availability of supply or other factors.
In all provinces in Canada, with a prescription from your healthcare provider, RSVpreF (AbrysvoTM, Pfizer), the new vaccine given to pregnant people between 32 and 36 weeks gestation, is available as a choice to protect infants from birth to six months of age. In Canada the list cost is approximately $230 5 and it is available for purchase in pharmacies with a prescription from your healthcare provider, it is covered by most private health insurance plans and in Ontario it is covered by the province at no cost to the patient.
In Quebec, Yukon and Nunavut, Nirsevimab (BeyfortusTM, Sanofi), the new monoclonal antibody given to the baby, preferably at birth before leaving the birth setting, will be offered through the provincial program at no cost to the patient. It is not available for purchase in pharmacies, it is only available through the provincial programs.* Pregnant people can still get the maternal RSV vaccine RSVpreF (AbrysvoTM, Pfizer) in these provinces if they have a prescription from their HCP and have private insurance or can pay out-of-pocket.
In Ontario, Nirsevimab (BeyfortusTM, Sanofi), the new monoclonal antibody given to the baby, preferably at birth before leaving the birth setting, will be offered through the provincial program at no cost to the patient. It is not available for purchase in pharmacies, it is only available through the provincial program.* The maternal RSV vaccine RSVpreF (AbrysvoTM, Pfizer) is also available to pregnant individuals in Ontario at no cost to the patient who will deliver near the start of or during the 2024-25 season. A prescription from your healthcare provider is needed. NACI recommends Beyfortus as the preferred product to protect infants.
In British Columbia, Alberta and Saskatchewan, the older multi-dose, monoclonal antibody, Palivizumab (Synagis®, AstraZeneca) will continue to be used for RSV protection in high-risk infants only. In these provinces, pregnant people can still get the maternal RSV vaccine RSVpreF (AbrysvoTM, Pfizer) if they have a prescription from their HCP and have private insurance or can pay out-of-pocket.
Other provinces are still evaluating their infant RSV programs or have not yet publicly released updated information for this RSV season.
This information is changing and will be updated periodically as new information becomes available. It may not be accurate or reflect the most current, up to date information on coverage and provincial programs. Please check with your healthcare provider and your provincial program to confirm your options for infant RSV protection this RSV season.
* List price in Canada for Nirsevimab (BeyfortusTM, Sanofi) is $952 5 and is only available through the provincial program, it is not available for purchase in pharmacies.
